KJHP
CELU icon

K.J. Harrison & Partners’s Celularity CELU Stock Holding History

K.J. Harrison & Partners’s Portfolio CELU Stock Details CELU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-5,980
Closed -$658K – 350
2020
Q4 		$658K Buy
5,980
+4,480
+299% +$476K 0.11% 186
2020
Q3 		$158K Buy
+1,500
New +$155K 0.03% 210

Other funds holding CELU

GCL
Glazer Capital LLC New York $4.07B AUM 78.71% 1-Year Est. Return
WRBC
W.R. Berkley Corp Greenwich, Connecticut $2.18B AUM 13.58% 1-Year Est. Return
BCM
BlueCrest Capital Management St Helier, Jersey $3.04B AUM 26.78% 1-Year Est. Return
TAL
TIG Advisors LLC New York $2.26B AUM 81.38% 1-Year Est. Return
SC
Shay Capital New York $1.56B AUM 46.17% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
MSU
Mizuho Securities USA New York $6.2B AUM 35.46% 1-Year Est. Return
HSBC Holdings
HSBC Holdings London, United Kingdom $239B AUM 42.32% 1-Year Est. Return
WAM
Weiss Asset Management Boston, Massachusetts $9.54B AUM 55.06% 1-Year Est. Return

K.J. Harrison & Partners's CELU Position: Q1 2021 in Review

K.J. Harrison & Partners sold out of Celularity (CELU) in Q1 2021, closing a stake of 5,980 shares — an estimated $658K sold.

K.J. Harrison & Partners first reported a position in CELU in Q3 2020 and held it in 2 quarters. The position peaked at $658K in Q4 2020. 63 funds tracked by Wall St. Rank hold CELU as of Q1 2021.

  • K.J. Harrison & Partners reported no remaining Celularity position as of Q1 2021 after selling out during the quarter.
  • K.J. Harrison & Partners sold 5,980 Celularity shares in Q1 2021, an estimated $658K.
  • K.J. Harrison & Partners first reported a position in Celularity in Q3 2020 and held it in 2 quarters.
  • K.J. Harrison & Partners's Celularity position peaked at $658K in Q4 2020.
  • 63 funds tracked by Wall St. Rank held Celularity as of Q1 2021.

Based on K.J. Harrison & Partners's 13F filing for Q1 2021, filed 14 May 2021.